Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-04 · 16d old
How a revenue dollar becomes profit — FY2016
Each value shows its share of revenue below it (common-size).
| Line Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.18T 100.0% | $1.03T 100.0% | $875.11B 100.0% | $709.37B 100.0% | $681.36B 100.0% | $675.60B 100.0% | $572.47B 100.0% |
| Cost of Revenue | $908.31B 77.1% | $786.49B 76.5% | $674.90B 77.1% | $572.63B 80.7% | $523.73B 76.9% | $500.03B 74.0% | $421.19B 73.6% |
| Cost of Products | $908.31B 77.1% | $786.49B 76.5% | $674.90B 77.1% | $572.63B 80.7% | $523.73B 76.9% | $500.03B 74.0% | $421.19B 73.6% |
| Research & Development | $51.98B 4.4% | $45.18B 4.4% | $37.81B 4.3% | $34.28B 4.8% | $30.05B 4.4% | $27.74B 4.1% | $24.27B 4.2% |
| Selling, General & Admin | $93.46B 7.9% | $85.78B 8.3% | $77.53B 8.9% | $84.76B 11.9% | $55.47B 8.1% | $55.35B 8.2% | $46.81B 8.2% |
| Total Operating Expenses | $1.05T 89.4% | $917.45B 89.2% | $790.25B 90.3% | $691.67B 97.5% | $609.25B 89.4% | $583.12B 86.3% | $492.27B 86.0% |
| Operating Income | $124.54B 10.6% | $110.94B 10.8% | $84.86B 9.7% | $17.60B 2.5% | $73.07B 10.7% | $92.87B 13.7% | $79.28B 13.8% |
| Interest Expense | $2.23B 0.2% | $1.49B 0.1% | $1.53B 0.2% | $679.0M 0.1% | $299.0M 0.0% | $355.0M 0.1% | $690.0M 0.1% |
| Other Income (Expense), net | -$5.21B -0.4% | -$3.85B -0.4% | -$404.0M -0.0% | -$4.20B -0.6% | -$2.21B -0.3% | -$10.90B -1.6% | -$3.31B -0.6% |
| Pretax Income | $119.33B 10.1% | $107.09B 10.4% | $84.46B 9.7% | $13.40B 1.9% | $70.86B 10.4% | $81.97B 12.1% | $75.97B 13.3% |
| Income Tax Expense | $26.47B 2.2% | $29.03B 2.8% | $25.66B 2.9% | $6.56B 0.9% | $18.80B 2.8% | $18.31B 2.7% | $17.57B 3.1% |
| Net Income | $91.81B 7.8% | $76.02B 7.4% | $56.27B 6.4% | $7.99B 1.1% | $40.73B 6.0% | $52.33B 7.7% | $51.96B 9.1% |
| Per Share | |||||||
| EPS (Basic) | $309.32 | $271.61 | $206.82 | $29.64 | $148.12 | $375.91 | $373.04 |
| EPS (Diluted) | $308.19 | $256.05 | $193.50 | $27.49 | $138.45 | $362.80 | $373.04 |
| Weighted Avg Shares (Basic) | 296.8M | 279.9M | 272.1M | 269.4M | 275.0M | 139.2M | 139.3M |
| Weighted Avg Shares (Diluted) | 297.9M | 296.7M | 290.5M | 288.3M | 293.8M | 144.2M | 139.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $23.7B dividends + $12.1B buybacks = $35.8B returned.
2 consecutive years of dividend increases · 7%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 11%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $305.9B covers the $29.2B due within a year 10.5× over. Scheduled principal only (excludes interest & revolver draws). As of 2014-03-31 (20-F).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~2.7% on $81.1B of debt.
Cash of $305.9B fully covers short-term debt of $81.1B.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-04
No material risks flagged.
Where each multiple sits in its own 5-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2016 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | 73.6 | 74.0 | 76.9 | 80.7 | 77.1 | 76.5 | 77.1 |
| R&D | 4.2 | 4.1 | 4.4 | 4.8 | 4.3 | 4.4 | 4.4 |
| SG&A | 8.2 | 8.2 | 8.1 | 11.9 | 8.9 | 8.3 | 7.9 |
| Operating Income | 13.8 | 13.7 | 10.7 | 2.5 | 9.7 | 10.8 | 10.6 |
| Income Tax | 3.1 | 2.7 | 2.8 | 0.9 | 2.9 | 2.8 | 2.2 |
| Net Income | 9.1 | 7.7 | 6.0 | 1.1 | 6.4 | 7.4 | 7.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on NJDCY: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 633 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $33.13T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $405.3B | 46.3× | 32.2× | 6.0× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $399.8B | 46.8× | — | 8.7× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $298.4B | 44.8× | 21.3× | 3.4× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| ABBNY | $187.8B | 50.7× | 33.5× | 5.8× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $175.3B | 24.7× | 16.7× | 7.2× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $173.5B | 42.8× | — | 6.3× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| DE | $165.5B | 33.1× | — | 3.6× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| HON | $157.6B | 33.7× | 18.9× | 4.2× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| HTHIF | $153.6B | 0.7× | — | 0.0× | 3.9% | 25.2% | 2.6% | 16.6% | 7.4% | — | 2 |
| LMT | $132.3B | 26.9× | 17.0× | 1.8× | 5.6% | 10.2% | 6.7% | 74.6% | 18.4% | 2.4× | 2,807 |
| PH | $127.9B | 36.8× | 28.7× | 6.4× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| HWM | $117.0B | 78.5× | 51.2× | 14.2× | 11.1% | — | 18.3% | 28.2% | 18.4% | 1.2× | 1,399 |
| ADP | $109.5B | 27.1× | — | 5.3× | 7.1% | 46.0% | 19.8% | 65.9% | 40.1% | — | 2,179 |
| TT | $107.8B | 37.3× | 26.5× | 5.1× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $106.3B | 81.5× | 50.3× | 10.4× | 27.7% | 36.3% | 13.0% | 33.8% | 19.5% | 1.4× | 1,748 |
| GD | $103.9B | 24.9× | 18.1× | 2.0× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| PWR | $102.2B | 100.4× | 50.3× | 3.6× | 20.3% | 15.0% | 3.7% | 11.7% | 11.7% | 0.0× | 1,659 |
| JCI | $100.1B | 30.6× | — | 4.2× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| MMM | $96.6B | 30.4× | 18.4× | 3.9× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| CSX | $95.1B | 33.2× | 15.3× | 6.8× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| EMR | $91.4B | 40.2× | — | 5.1× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| UPS | $91.4B | 16.4× | 10.1× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| WM | $90.4B | 33.5× | 12.7× | 3.6× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| CMI | $89.7B | 31.7× | 16.9× | 2.7× | -1.3% | 25.3% | 8.8% | 23.9% | 23.9% | — | 1,877 |
| NJDCY | $1.3B | 0.0× | -1.2× | 0.0× | 14.6% | 22.9% | 7.8% | 12.0% | 10.9% | 0.5× | 7 |
Peers = companies sharing NJDCY's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 7 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position